DEPTOR and prostate adenocarcinoma: In addition, DEPTOR amplification directly correlates with worse disease/progression-free survival in the TCGA Firehose Legacy prostate adenocarcinoma dataset (Figure S4), indicating DEPTOR amplification may provide a valuable predictive biomarker in the clinic.